Patents by Inventor Harmen Jacob Geerligs

Harmen Jacob Geerligs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220175911
    Abstract: Poultry vaccines against infectious bronchitis and Turkey Rhinotracheitis are provided. The vaccines are adjuvanted with oil emulsion containing an immunostimulatory oligonucleotide. The methods of using the vaccines are also provided.
    Type: Application
    Filed: July 13, 2021
    Publication date: June 9, 2022
    Inventors: Carla Maria Batista de Freitas, Maria Carolina Ferreira dos Santos, Paul Joseph Dominowski, Harmen Jacob Geerligs
  • Patent number: 11103573
    Abstract: Poultry vaccines against infectious bronchitis and Turkey Rhinotracheitis are provided. The vaccines are adjuvanted with oil emulsion containing an immunostimulatory oligonucleotide. The methods of using the vaccines are also provided.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: August 31, 2021
    Assignee: Zoetis Services LLC
    Inventors: Carla Maria Batista de Freitas, Maria Carolina Ferreira dos Santos, Paul Joseph Dominowski, Harmen Jacob Geerligs
  • Publication number: 20190240315
    Abstract: Poultry vaccines against infectious bronchitis and Turkey Rhinotracheitis are provided. The vaccines are adjuvanted with oil emulsion containing an immunostimulatory oligonucleotide. The methods of using the vaccines are also provided.
    Type: Application
    Filed: May 31, 2017
    Publication date: August 8, 2019
    Inventors: Carla Maria Batista de Freitas, Maria Carolina Ferreira dos Santos, Paul Joseph Dominowski, Harmen Jacob Geerligs
  • Patent number: 9296991
    Abstract: The present invention relates to infectious bronchitis (IB) viruses derived from a recently identified genotype of IB virus known as IB-QX, or from viruses that are genetically related to IB-QX, herein referred to as IB-QX-like viruses. The IB viruses of the invention may be live and attenuated or inactivated. Live, attenuated IB viruses of the invention may be produced by serial passaging of an IB-QX-like virus. The IB viruses of the invention are useful for, inter alia, vaccines against IB-QX and IB-QX-like viruses. Heretofore, known vaccine strains of IB viruses have proven insufficient to protect against infectious bronchitis caused by IB-QX and IB-QX-like viruses.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: March 29, 2016
    Assignee: Zoetis Services LLC
    Inventors: Harmen Jacob Geerligs, Cindy Aleida Maria Meinders, Geert Jan Boelm, Bastiana Geertruida Elisabeth Stuurman
  • Publication number: 20110305726
    Abstract: The present invention relates to infectious bronchitis (IB) viruses derived from a recently identified genotype of IB virus known as IB-QX, or from viruses that are genetically related to IB-QX, herein referred to as IB-QX-like viruses. The IB viruses of the invention may be live and attenuated or inactivated. Live, attenuated IB viruses of the invention may be produced by serial passaging of an IB-QX-like virus. The IB viruses of the invention are useful for, inter alia, vaccines against IB-QX and IB-QX-like viruses. Heretofore, known vaccine strains of IB viruses have proven insufficient to protect against infectious bronchitis caused by IB-QX and IB-QX-like viruses.
    Type: Application
    Filed: August 7, 2009
    Publication date: December 15, 2011
    Applicant: Wyeth LLC
    Inventors: Harmen Jacob Geerligs, Cindy Aleida Maria Meinders, Geert Jan Boelm, Bastiana Geertruida Elisabeth Stuurman